Placebo matching UCB0599 and without active substance clinical trials

A DOSE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF UCB0599 IN STUDY PARTICIPANTS WITH PARKINSON’S DISEASE

This study is testing a new medicine, UCB0599, for Parkinson's disease. Researchers want to see if it's safe, how well it works long-term, and if it helps protect brain cells. They are comparing it to a dummy pill.